HomeENTA • NASDAQ
add
Enanta Pharmaceuticals Inc
Previous close
$7.23
Day range
$7.20 - $7.43
Year range
$4.71 - $17.80
Market cap
156.15M USD
Avg Volume
453.17K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 16.96M | -5.80% |
Operating expense | 40.50M | -23.42% |
Net income | -22.29M | 33.28% |
Net profit margin | -131.43 | 29.17% |
Earnings per share | -1.05 | 33.54% |
EBITDA | -22.65M | 33.85% |
Effective tax rate | 1.83% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 216.69M | -35.73% |
Total assets | 348.64M | -18.64% |
Total liabilities | 236.83M | 0.09% |
Total equity | 111.82M | — |
Shares outstanding | 21.33M | — |
Price to book | 1.38 | — |
Return on assets | -16.23% | — |
Return on capital | -17.11% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -22.29M | 33.28% |
Cash from operations | -16.80M | 32.76% |
Cash from investing | 68.90M | 625.30% |
Cash from financing | -4.99M | 32.16% |
Net change in cash | 47.12M | 203.65% |
Free cash flow | -24.17M | -35.93% |
About
Founded
1995
Headquarters
Website
Employees
131
